218.99USD+4.06%Mkt Cap: —P/E: 25.451d ago
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, L…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value177.19B $
Revenue (TTM)25.11B $
Gross Profit14.75B $
Net Income (TTM)3.99B $
Revenue/Share35.47 USD
Last Price218.99 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees58.0K
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)25.45
P/E (Forward)—
PEG—
EV/EBITDA22.07
EV/Revenue7.06
P/S—
P/B2.93
EPS (TTM)8.64
EPS (Forward)—
52W Range
198.0093% of range220.65
52W High220.65 USD
52W Low198.00 USD
Profitability
Gross Margin58.75%
Oper. Margin19.78%
EBITDA Margin31.97%
Profit Margin15.95%
ROE7.61%
ROA3.95%
Growth
Revenue Growth5.50%
Earnings Growth59.70%
Cash Flow & Leverage
Operating CF6.63B $
CapEx (TTM)—
FCF Margin17.23%
FCF Yield—
Net Debt23.51B $
Net Debt/EBITDA2.93
Balance Sheet
Debt/Equity52.97
Current Ratio1.65
Quick Ratio1.15
Book Value/Sh74.81 USD
Cash/Share6.185 USD
Dividends
Fwd Div Rate—
Trail. Div Rate1.440 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.700.90M
Float625.83M
Insiders10.96%
Institutions84.50%
Technical
SMA 50242.48 (-9.7%)
SMA 200235.35 (-6.9%)
Beta0.80
S&P 52W Chg18.16%
Avg Vol (30d)2.78K
Avg Vol (10d)24.57K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—